As Principal Biostatistician, adept at utilizing advanced statistical methods, you will support or lead multiple nonclinical projects. As part of this role, you will need to work in an unique scientific and collaborative environment for fast-moving projects, often under short timeline.
- Leading multiple nonclinical or manufacturing statistics supporting a big pharmaceutical company.
- Responsible for rigorous statistical methods to design experiments, analyze complex biological data, and support decision-making throughout the early drug development process
- Collaborate closely with scientists, toxicologists, regulatory experts, and data teams to ensure high-quality, interpretable results that accelerate the development of new medicines.
- Strong experiences in end‑to‑end statistical support across the product lifecycle, including analytical method development and validation, formulation development and robustness, and process development and validation—aligned with regulatory standards such as FDA, EMA, ICH, and USP
- Good oral and written skills are crucial, as is the desire to learn enough of the relevant science to interact effectively.
- Exposure to modern data analysis techniques and experiences such as data visualization, robust statistics and analysis of high-dimensional data is desirable.
- Constantly eager to expand statistical, communications, and computing expertise.
- Must enjoy the process of building long-term collaborative relationships, be at ease with either a non-rigid or rigid structure to projects and be organized in handling numerous projects simultaneously.
- PhD in Statistics or related field
- Solid knowledge of linear mixed models, multivariate analysis, design of experiments and Bayesian statistics is essential.
- Proficiency in the R language is required with the development of automated, reproducible workflows using R Markdown and Quarto to enhance regulatory submission readiness.
- Demonstrated written, oral, and personal communication skills.
- Ability to work autonomously and within a team environment.
- Demonstrated ability to work in interdisciplinary contexts outside statistics.
Cytel Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Cytel and has not been reviewed or approved by Cytel.
-
Healthcare Strength — Health coverage is described as comprehensive, spanning medical, dental, vision, life and disability, with FSAs/HSAs also available. Plan quality is often characterized as good to excellent, which lifts the perceived value of the overall package.
-
Retirement Support — A 401(k) with employer match is consistently part of the benefits package. The plan is also characterized as well managed, contributing to a sense of baseline retirement support.
-
Fair & Transparent Compensation — Overall pay is characterized as decent-to-good and broadly competitive in parts of the business, with stronger alignment noted in senior technical tracks like biostatistics and programming. The total package is often framed as respectable rather than premium.
Cytel Insights
Similar Jobs
What We Do
Cytel enables decision-makers in the life sciences to unlock the full potential of their products. From navigating uncertainty to proving value, Cytel’s 30 years of global expertise in consulting, data-driven analytics, and industry-leading software helps biotech and pharmaceutical companies transform intelligence into confident decisions. We have an uncompromising commitment to scientific rigor and high standards of operational excellence, which are channeled through our locations in North America, Europe, the United Kingdom, and Asia. Together, we enable our clients to deliver the therapies that propel humanity forward. Cytel employs a range of data science tools from biostatistics to machine learning to help executives in the life-sciences to make confident decisions powered by data. We are probably best known for being leaders in the field of adaptive clinical trial design, a subset of trial design that uses interim looks to enhance the patient safety and commercial value of pharmaceutical products. We also have specialists in Bayesian statistics, real world evidence, artificial intelligence, health economics, and a number of other research fields to ensure that academic and scientific findings can have impact on industry quickly and seamlessly. www.cytel.com








